Cargando…
Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540”
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616458/ https://www.ncbi.nlm.nih.gov/pubmed/34830859 http://dx.doi.org/10.3390/cancers13225705 |
_version_ | 1784604353459388416 |
---|---|
author | Hosmann, Arthur Millesi, Matthias Wadiura, Lisa I. Kiesel, Barbara Mercea, Petra A. Mischkulnig, Mario Borkovec, Martin Furtner, Julia Roetzer, Thomas Wolfsberger, Stefan Phillips, Joanna J. Berghoff, Anna S. Hervey-Jumper, Shawn Berger, Mitchel S. Widhalm, Georg |
author_facet | Hosmann, Arthur Millesi, Matthias Wadiura, Lisa I. Kiesel, Barbara Mercea, Petra A. Mischkulnig, Mario Borkovec, Martin Furtner, Julia Roetzer, Thomas Wolfsberger, Stefan Phillips, Joanna J. Berghoff, Anna S. Hervey-Jumper, Shawn Berger, Mitchel S. Widhalm, Georg |
author_sort | Hosmann, Arthur |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8616458 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86164582021-11-26 Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540” Hosmann, Arthur Millesi, Matthias Wadiura, Lisa I. Kiesel, Barbara Mercea, Petra A. Mischkulnig, Mario Borkovec, Martin Furtner, Julia Roetzer, Thomas Wolfsberger, Stefan Phillips, Joanna J. Berghoff, Anna S. Hervey-Jumper, Shawn Berger, Mitchel S. Widhalm, Georg Cancers (Basel) Reply MDPI 2021-11-15 /pmc/articles/PMC8616458/ /pubmed/34830859 http://dx.doi.org/10.3390/cancers13225705 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Reply Hosmann, Arthur Millesi, Matthias Wadiura, Lisa I. Kiesel, Barbara Mercea, Petra A. Mischkulnig, Mario Borkovec, Martin Furtner, Julia Roetzer, Thomas Wolfsberger, Stefan Phillips, Joanna J. Berghoff, Anna S. Hervey-Jumper, Shawn Berger, Mitchel S. Widhalm, Georg Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540” |
title | Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540” |
title_full | Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540” |
title_fullStr | Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540” |
title_full_unstemmed | Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540” |
title_short | Reply to Stummer, W.; Thomas, C. Comment on “Hosmann et al. 5-ALA Fluorescence Is a Powerful Prognostic Marker during Surgery of Low-Grade Gliomas (WHO Grade II)—Experience at Two Specialized Centers. Cancers 2021, 13, 2540” |
title_sort | reply to stummer, w.; thomas, c. comment on “hosmann et al. 5-ala fluorescence is a powerful prognostic marker during surgery of low-grade gliomas (who grade ii)—experience at two specialized centers. cancers 2021, 13, 2540” |
topic | Reply |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616458/ https://www.ncbi.nlm.nih.gov/pubmed/34830859 http://dx.doi.org/10.3390/cancers13225705 |
work_keys_str_mv | AT hosmannarthur replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540 AT millesimatthias replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540 AT wadiuralisai replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540 AT kieselbarbara replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540 AT merceapetraa replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540 AT mischkulnigmario replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540 AT borkovecmartin replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540 AT furtnerjulia replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540 AT roetzerthomas replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540 AT wolfsbergerstefan replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540 AT phillipsjoannaj replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540 AT berghoffannas replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540 AT herveyjumpershawn replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540 AT bergermitchels replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540 AT widhalmgeorg replytostummerwthomasccommentonhosmannetal5alafluorescenceisapowerfulprognosticmarkerduringsurgeryoflowgradegliomaswhogradeiiexperienceattwospecializedcenterscancers2021132540 |